Identifier |
20170406_nanos_nosideeffects1_03-abstract |
Title |
Side Effects of New Immuno-Modulators (abstract) |
Creator |
Ore-ofe Oluwaseun Adesina |
Affiliation |
Ruiz Department of Ophthalmology and Visual Science at the McGovern Medical School Houston, Houston, TX |
Subject |
Rheumatologic Drugs; Biologics; Demyelination; Visual Loss |
Description |
Medications used in the management of rheumatologic disorders include therapeutic agents with varying mechanisms of action. The older well known drugs include glucocorticoids, non-steroidal anti-inflammatory drugs and the antimetabolites and cytotoxic medications such as cyclophosphamide, mycophenolate mofetil, methotrexate and azathioprine (disease modifying anti-rheumatic drugs - DMARDs). Of particular interest, however, are the drugs known as biologics. These drugs are not derived from compounds with predictable chemical structures; rather they are complex molecules or mixtures of molecules that are produced by the cells of living microorganisms, plants or animals, often using recombinant DNA. |
Date |
2017 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2017 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis |
Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
Publisher |
North American Neuro-Ophthalmology Society |
Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management |
Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6k68c64 |
Setname |
ehsl_novel_nam |
ID |
1273220 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6k68c64 |